GlaxoSmithKline Pharmaceuticals Ltd

NSE: GLAXO · BSE: 500660 · Pharmaceuticals & Biotechnology · 34 announcements

Share price: ₹2,755.00
Market cap: ₹46,671 Cr
Revenue (annual): ₹3,822 Cr
Net profit (annual): ₹1,036 Cr
P/E (TTM): 43.7×Sector 47.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 4.79%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Management Change 5 Annual General Meeting 5 Other Announcement 4 Financial Results 3 Results Update 2 Legal & Regulatory 2 Board Meeting Outcome 2 Price Movement Clarification 1 Dividend 1 Business Update 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

6 Aug 2026 19:47 IST BSE

Legal & Regulatory

GlaxoSmithKline Pharmaceuticals Legal & Regulatory

GlaxoSmithKline Pharmaceuticals received a ₹52.00 Crore tax refund plus ₹42.09 Crore interest income following a favorable CIT-Appeal order for assessment year 1984-85.

Value: ₹94.09 Cr

Read the filing ↗

25 Jun 2026 11:38 IST BSE

Legal & Regulatory

GlaxoSmithKline Pharmaceuticals Legal & Regulatory

GlaxoSmithKline Pharmaceuticals received a Demand Notice from NPPA demanding Rs.3,54,12,025. The company says the demand has no financial impact and will appeal.

Value: ₹3.54 Cr

Read the filing ↗